Streetbeat News

Products Services

BTCUSD

ETHUSD

GBTC

A survey funded by Grayscale reveals that one-third of U.S. voters will consider a political candidate's stance on cryptocurrencies in the 2024 elections. The survey highlights the growing importance of crypto in political campaigns and investment portfolios, with significant awareness and investment in Bitcoin and Ethereum. The introduction of Ether ETFs and the desire for more regulation are also noted.

Portfolio Pulse from Murtuza Merchant

May 28, 2024 | 4:44 pm

GETY

Getty Images Holdings, Inc. (NYSE: GETY) shares are up 4.11% to $3.55 following a partnership with FILMPAC to distribute premium stock footage. The collaboration aims to meet the high-quality content demands of Getty's clients. Despite a 5.2% year-over-year decrease in Creative revenue in Q1, the company continues to expand its offerings, including the recent acquisition of Motorsport Images.

Portfolio Pulse from Nabaparna Bhattacharya

May 28, 2024 | 4:38 pm

FEPI

GGME

MSFT

NFLX

Netflix Inc (NASDAQ:NFLX) may discontinue offline viewing on its Microsoft Corp (NASDAQ:MSFT) Windows app, according to multiple posts on X. The change will likely come with an upcoming update, but offline downloads will still be available on supported mobile devices. Netflix's ad-supported subscription plan has grown significantly, and the company reported strong first-quarter financial results. Netflix stock has gained over 64% in the last 12 months.

Portfolio Pulse from Anusuya Lahiri

May 28, 2024 | 4:25 pm

AMC

CNK

DIS

SONY

WBD

The Memorial Day weekend box office recorded its worst performance in three decades, with new releases 'Furiosa' and 'The Garfield Movie' failing to attract significant audiences. This continues a trend of declining ticket sales, exacerbated by ongoing Hollywood strikes and competition from streaming platforms.

Portfolio Pulse from Chris Katje

May 28, 2024 | 4:25 pm

COIN

The memecoin market is seeing a resurgence with Floki (FLOKI) and Dogwifhat (WIF) leading the charge. Floki surged 22% after announcing a major marketing campaign and being listed for futures trading on Coinbase. Dogwifhat saw a 12% rise due to a breakout from a symmetrical triangle pattern and significant buying pressure. Despite gains, analysts remain cautious about the long-term prospects of both tokens.

Portfolio Pulse from Murtuza Merchant

May 28, 2024 | 4:17 pm

EIS

ISRA

U.S. aid deliveries to Gaza by sea have been suspended due to damage to a temporary pier system caused by bad weather. The repairs are expected to take a week. This suspension is a setback for the aid operation that started two weeks ago.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 4:15 pm

ARM

GOOG

INTC

MSFT

NVDA

QCOM

Rosenblatt analyst Hans Mosesmann reiterated a Buy rating on Arm Holdings (NASDAQ:ARM) with a price target of $180, citing strong licensing interest and growth potential in AI and datacenter markets. Nvidia (NASDAQ:NVDA) and Arm are highlighted as top picks for long-term growth.

Portfolio Pulse from Anusuya Lahiri

May 28, 2024 | 4:02 pm

APDN

CALT

GME

INSM

MRAI

NCPL

PEGY

U.S. stocks traded mixed with the Dow Jones falling over 100 points, while the NASDAQ and S&P 500 saw gains. GameStop shares spiked 24% after completing an equity offering. Insmed, Calliditas Therapeutics, and Pineapple Energy saw significant gains, while Applied DNA Sciences, Marpai, and Netcapital experienced sharp declines.

Portfolio Pulse from Avi Kapoor

May 28, 2024 | 4:00 pm

TMUS

USM

T-Mobile US, Inc. (NASDAQ: TMUS) announced it will acquire nearly all of UScellular's (NYSE: USM) wireless operations for approximately $4.4 billion. The acquisition will expand T-Mobile's network to millions of new customers, particularly in underserved rural areas. The deal will be financed with a combination of cash and up to $2 billion of debt. T-Mobile customers will benefit from enhanced network performance and coverage.

Portfolio Pulse from Dylan Berman

May 28, 2024 | 3:59 pm

NVO

Novo Nordisk (NYSE:NVO) is under scrutiny for the high prices of its diabetes and obesity drugs, Ozempic and Wegovy. The company retains about 60% of the list price after rebates and fees. Senator Bernie Sanders is urging price reductions, highlighting the disparity between production costs and market prices. Novo Nordisk defends its pricing, citing significant investment in drug development. The potential market for GLP-1 drugs could reach $150 billion by the early 2030s.

Portfolio Pulse from Vandana Singh

May 28, 2024 | 3:59 pm